MTOR Inhibitor Temsirolimus CAS 162635-04-3

Temsirolimus CAS 162635-04-3 is also called CCI-779, NSC 683864, Torisel and Sirolimus which is a specific inhibitor of mTOR with IC50 of 1.76 μM. It can soluble to 100 mM in DMSO and to 100 mM in ethanol. The Temsirolimus CAS NO 162635-04-3, supplied by us, is high purity, less impurity, premium quality and safe formulation. Temsirolimus (CCI-779) 162635-04-3 is also an intravenous drug for the treatment of renal cell carcinoma (RCC). We can arrange fast delivery and offer best service.

Thera. Category: Anti angiogenic

Cas No.: 162635-04-3

Synonym: TEMSIROLIMUS;CCL-779;Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate;42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin;C15182;TeMsiroliMus (CCI-779, Torisel);rapaMycin 42-ester with 3-hydroxy-2-(hydroxyMethyl)-2-Methylpropionic acid;TeMsiroliMus (Torisel)

Molecular Formula: C56H87NO16

Molecular Weight: 1030.29

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage:Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007,[2] and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative and prodrug of sirolimus.

Product Categories : Inhibitors > MTOR Inhibitor